About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Tissue Engineering, Parts A, B, & C

Co-Editors-in-Chief: Antonios G. Mikos, PhD and Peter C. Johnson, MD
Reviews Co-Editor-In-Chief (Part B): John P. Fisher, PhD
Methods Co-Editor-In-Chief (Part C): John A. Jansen, DDS, PhD

ISSN: 2152-4947 • Online ISSN: 2152-4955

Latest Impact Factor* is 4.254

*2013 Journal Citation Reports® published by Thomson Reuters, 2014

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions

    The goal of Tissue Engineering is to inform its readers of significant developments in areas related to tissue engineering. This Journal provides a forum for responsible discussion among identified individuals. Significant papers on any aspect of tissue engineering are invited for publication. 

    In order to help defray the costs of processing and reviewing, the Journal requires a nonrefundable, per-manuscript submission fee of $95.00 USD regardless of final editorial decision.

    Manuscripts must be submitted online using the following url:  http://mc.manuscriptcentral.com/ten

    Please read all the instructions to authors before submitting.

    The ultimate decision regarding assignment of manuscripts is left to the discretion of the Editors-in-Chief.  At any time prior to publication the Editors of Tissue Engineering may reassign an article from one Part of Tissue Engineering to another.

    Language must conform to acceptable English usage and syntax. The contents must be clear, accurate, coherent, and logical. In accepting, rejecting or reassigning a manuscript to another Part of the journal, the editors will also consider its originality, teaching value, and validity.

    Manuscripts should not exceed approximately 4,000 words.  Because of space limitations, the authors should be frugal with their illustrations. Occasional exceptions will be made for prize-winning essays, collective reviews, solicited material, or special works. To facilitate a quick review of manuscripts, authors are encouraged to suggest names of five potential reviewers with complete contact information when the manuscript is submitted.

    For further information about editorial questions on papers in the online peer-review process, please contact Carol Lofton at (713) 348-4204 or TEeditor@rice.edu.

    For technical information on using Manuscript Central, contact Patricia Meravy  at (914) 740-2132 or PMeravy@liebertpub.com.


    Manuscript Submission and Review

    To help defray the cost of printing, the publisher requests that page charges of $75 per printed page be paid by all authors who have funds available from research grants or from their institutions. It should be noted that ability to pay page charges is not a prerequisite for publication in the Journal.

    Decisions concerning journal assignment, editing, revisions, acceptances, and rejections will be made by the editors. These may include reassigning an article from one Part of Tissue Engineering to another, shortening the paper, reducing the number of illustrations and tables, or changing format.  An accepted paper may be published with an accompanying discussion if the editors so desire.

    Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publications should be described in the form of a footnote to the title.  Published manuscripts become the sole property of the Journal and will be copyrighted. By submitting a paper to the Journal, the author (or authors) agrees to each of the above conditions. In addition, the author (or authors) explicitly assigns any copyrighted ownership he/she (or they) may have in such paper to the Journal.

    Preparation of Manuscripts

    Papers must be submitted via upload in a word processing format, preferably in Microsoft Word. Please do not include artwork within the text document. Figures should be supplied in separate files, be labeled clearly, and should be in TIFF or EPS formats. Tables should be submitted in Word.  Please see the Illustrations section for further details on art submission.

    All copy must be double-spaced, including text, footnotes, references, legends, and tables. Text references must be supplied in sequence for all tables and figures.  The title page should carry the full paper title, followed by the authors’ names, degrees, and where the work was performed. We require the full mailing address and contact information (telephone, fax and e-mail address for EACH author). Please indicate the corresponding author.

    An abstract should accompany every original paper. Case Reports and Ideas and Innovations should include a summary. The abstract should appear on a separate page and should be at least 100 but not more than 350 words long. It should consist of factual information and not generalities (the problem investigated, the method used, the results obtained, and the conclusions reached). A brief introduction, materials and methods, results, discussion, acknowledgments, and reference sections should follow. At the conclusion of the references, the name and complete address of the reprint author should appear.

    Correspondence and brief communications are published at the discretion of the editors as space permits. They should be double-spaced, and must not exceed 500 words in length.


    The Journal publishes all accepted papers within 72 hours of acceptance in their unedited, uncorrected format.  It is important to note that the information that is published online, and in all indexing services, is pulled directly from the data that is populated into the fields in Manuscript Central – NOT from the manuscript file – when the paper is originally uploaded to the system for peer review.  Consequently, any errors contained in the system will remain on our website and all indexing services, including Medline, until the next revision of the article is published.  As such, it is critical that authors enter all authors’ names correctly into the system at the time of submission.

    The next revision will take place after the corresponding author sees page proofs, makes any necessary corrections, and returns the changes to the Publisher.  Once the alterations are completed, the revised version will be published on our website, and the newly corrected information will then be released to Medline/PubMed, in addition to any other indexing services in which the Journal is included.

    Please note that the typical time between acceptance of a paper and page proof distribution is approximately 4-8 weeks depending on the length and complexity of the paper.


    The references must be double-spaced and must be cited in the text in numerical order, not alphabetically. References to journal papers should include (1) author(s), (2) title, (3) journal name (as abbreviated in Medline), (4) volume number, (5) the first page number, and (6) year, in that order. References to books should include (1) author(s), (2) chapter title (if any), (3) editor (if any), (4) title of book, (5) city of publication, (6) publisher, (7) year, and (8) page range.  Volume and edition numbers, and name of translator should be included when appropriate. The author is responsible for the accuracy and completeness of the references.

    See the following samples:

    (Journal) Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.

    (Book chapter) Fung, Y.C.B. Stress-strain history relations of soft tissues in simple elongation. In: Fung, U.C.B., Perone, N., and Anliker, M., eds. Biomechanics: Its Foundations and Objectives. Englewood Clifts, NJ: Prentice-Hall Inc., 1972, pp. 181–208.

    (Book) Crank, J. The Mathematics of Diffusion. Oxford: Clarendon Press, 1975.

    (Other) Wong, L. Changes in intrinsic mechanical properties of articular cartilage using indentation tests of unstable knees [M.S. thesis].  Department of Mechanical and Aerospace Engineering, Case Western Reserve University, Cleveland, OH, 1995.

    (Abstract) Acarturk, T.O., Petrosko, P., Johnson, P.C., and DiMilla, P.A. Biomaterial-driven control of myoblast morphology, growth and attachment on silonized substrates. Abstract presented at the Tissue Engineering Society Meeting, Orlando, FL, 1996. Abstract no. xxx.

    Abbreviate journal names according to the style of Medline.

    Statistical Analysis

    If a statistical analysis is done, an explanation of how it was performed must be stated at the end of the section preceding results. Unusual or complex methods of analysis should be referenced.


    Please follow these guidelines for submitting figures:

    • Do NOT embed art files into a Word or PDF document. Figures provided in this format cannot be used for production purposes.
    • Line illustrations should be submitted at 600 dpi.
    • Halftones and color should be submitted at a minimum of 300 dpi.
    • Save as either TIFF or EPS files. JPEG files are for screen representation-quality only and will print very poorly during the printing process. To ensure proper print quality, please submit only TIFF or EPS files.
    • Color art must be saved as CYMK—not RGB. (NB: If RGB files are submitted, the files will be converted to CYMK and some color variation will occur.)
    • Black and white art must be submitted as grayscale—not RGB.
    • Do NOT submit PowerPoint, PDF, Bitmap, or Excel figure or table files. When naming your figure and table files, please label them with the main author’s last name, followed by a period (.), and then list the figure number. Ex: Smith.Fig1; Smith.Table1. Label figures and tables inside the files in addition to naming the file with the figure or table number. (i.e., When figures or table files are opened, the figure or table number should appear inside the file.)

    Additional Information about Converting Figure Files:

    Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:

    • ll files should be scanned at 100% size
    • 300 dpi
    • Final color mode: CMYK
    • Save file as: .tif or .eps

    If you need directions on how to convert a PowerPoint slide to acceptable format go to: www.liebertpub.com/MEDIA/pdf/ppconvert.pdf


    Legends are required for illustrations. They should be brief and pertinent. Legends for photomicrographs should identify the stain and state the magnification.

    Please keep in mind that the figures will be reduced, so please do not submit large figures/graphs that contain small type, as the text within the figure will not be readable after reduction.


    Please upload individual files of all manuscript material—do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.

    Cover Art: Authors are encouraged to submit outstanding color photographs for possible use as cover art. Photos should be submitted in two sizes: 8½  11'' or slightly larger for the cover, and at the size it will appear at in the published paper. For further information about submitting cover art, please contact Carol Lofton at (713) 348-4204 or TEeditor@rice.edu.

    Acknowledgments: Illustrations taken from other publications must be acknowledged by a complete credit line in the legend. The publisher’s letter of permission should be submitted to Tissue Engineering.

    Disclosure Statement

    Immediately following the Acknowledgments section, include a section entitled ‘‘Author Disclosure Statement.’’ This text must be part of your actual mansucript file.

    In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision.

    Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance. 

    If no conflicts exist, the authors must state ‘‘No competing financial interests exist.’’

    Page Proofs

    An e-mail containing a link to the PDF file of the page proof is sent to the corresponding author. The proof should be read carefully and returned promptly to the publisher with the author’s approval and/or corrections.


    Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.


    The Journal is published monthly by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215, Tel: (914) 740-2100; fax: (914) 740-2101; e-mail: info@liebertpub.com; online:  www.liebertpub.com

  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy

    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 




The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Stem Cells and Development

    Stem Cells and Development

    Globally recognized as the trusted source for critical, even controversial coverage of emerging hypotheses and novel findings on stem cells of all tissue types and their potential therapeutic applications.

    Biopreservation and Biobanking

    Biopreservation and Biobanking

    The first journal to provide a unifying forum for the peer-reviewed communication of recent advances in the emerging and evolving field of biospecimen procurement, processing, preservation, and banking.

    Human Gene Therapy

    Human Gene Therapy

    The definitive rapid-publication journal covering all aspects of gene therapy through original investigations into the transfer and expression of genes in mammals, with in-depth coverage of DNA, RNA, and cell therapies.

    Rejuvenation Research

    Rejuvenation Research

    Key explorations and cutting-edge advancements on the molecular and cellular mechanisms that may ultimately contribute to slowing or reversing the aging process.

Browse All Publications »